Specialists for Growth delay due to insulin-like growth factor I resistance

16 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

James Yao
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×2
Armando Santoro, MD
Rare Disease / Clinical Research
Istituto Clinico Humanitas
PI×19
Shancheng Ren, MD,PhD
Rare Disease / Clinical Research
Shanghai Changzheng Hospital
PI×2
Robert O'Donnell
Rare Disease / Clinical Research
University of California, Davis
PI×2
Andrew B Hassan, BMBCh FRCP
Rare Disease / Clinical Research
University of Oxford
PI×1
Alberto Chiappori, MD
Rare Disease / Clinical Research
Moffitt Cancer Center
TAMPA, FL
PI×1
Kevin Judy, MD, MD
Rare Disease / Clinical Research
Thomas Jefferson University
PHILADELPHIA, PA
PI×1
Eric Burak, PhD
Rare Disease / Clinical Research
Centre for Probe Development and Commercialization
PI×1
Michael Bergqvist, M.D., Ph.D
Rare Disease / Clinical Research
Uppsala University Hospital
PI×1
David Camidge, MD
Rare Disease / Clinical Research
University of Colorado, Denver
AURORA, CO
PI×1
Simon Ekman, M.D., Ph.D.
Rare Disease / Clinical Research
Uppsala University Hospital
PI×1
Principal Investigator - Czech Republic
Rare Disease / Clinical Research
General Faculty Hospital, Charles University
PI×1
Principal Investigator - Italy
Rare Disease / Clinical Research
Instituto Europeo de Oncologia
PI×1
Noura MS Shehabeldin, M.B.B.Ch
Rare Disease / Clinical Research
Faculty of Medicine, Mansoura University.
PI×1
Michele Marinò, MD
Rare Disease / Clinical Research
University of Pisa
PI×1
Mohamed AA Zahran, M.D.
Rare Disease / Clinical Research
Faculty of Medicine, Mansoura University.
PI×1

More about Growth delay due to insulin-like growth factor I resistance